-- 中国の医薬品規制当局は、江蘇バイオパーフェクタス・テクノロジーズ（SHA:688399）に対し、特定のインフルエンザ型を対象とした体外診断用試薬の医療機器登録証を交付した。同社が木曜日に上海証券取引所に提出した開示書類で明らかになった。 このキットは、ヒトの咽頭ぬぐい液サンプルからインフルエンザA型、2009年型H1N1変異株、および季節性H3亜型インフルエンザウイルスを検出するのに役立つ、と同書類は述べている。
Related Articles
Mining & Metals
Canadian Natural Resources Maintained at Hold at TPH After Q1 Results; Price Target at C$70.00
Tudor, Pickering, Holt on Thursday maintained its hold rating on the shares of Canadian Natural Resources (CNQ.TO, CNQ) with a C$70.00 price target following first-quarter results from the country's No.1 oil producer."While generally expected given net debt levels exiting 2025, highlights from the overall update include the formal step-up in return-of-capital alongside the ~4% beat on Q1 cash flow. On Q1 results, headline metrics include C$4.37B AFFO vs. TPHe/Street consensus C$4.19B/C$4.26B (C$2.09/shr vs. TPHe/Street C$2.01/C$2.01), with the delta vs. our model owing to realizations and expenses more than offsetting production. 1,643mboepd came in slightly below TPHe/Street 1,657/1,651, primarily driven by Oil Sands with 275mbopd In Situ comparing to TPHe/Street 279/276 and 588mbopd OSM comparing to TPHe/Street 594/595, though the April run-rate within OSM of 630mbopd bodes well for Q2 (TPHe/Street 587/587). On the balance sheet and return of capital, net debt is now sufficiently below C$16B to have driven CNQ to plan for returning 75% of FCF to shareholders. This is already starting to take effect, with April buybacks already totaling ~$0.3B, matching full Q1's buyback activity ($1.5B in return of capital, consisting of $1.2B in dividends and $0.3B in share repurchases); no change to TPHe H2'27+ at strip for the final uplift to 100% with ND (covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $59.80, Change: $-2.46, Percent Change: -3.95%
$CNQ$CNQ.TO
Australia
Blackstone, I Squared Nearing $2.9 Billion Bid for Stroeer, Bloomberg Reports
Price: $123.31, Change: $-1.38, Percent Change: -1.11%
$BX
Australia
BMO Capital Adjusts American International Group Price Target to $89 From $83
American International Group (AIG) has an average rating of overweight and mean price target of $87.80, according to analysts polled by FactSet.Price: $77.12, Change: $-0.58, Percent Change: -0.74%
$AIG